Published 15 April 2009, doi:10.1136/bmj.b1284
Cite this as: BMJ 2009;338:b1284

Endgames

Picture Quiz

Petechial rash on the extremities

Stephanie St Pierre, medical student1, Marisa Potter, dermatology resident2, Scott P Prawer, dermatology resident (graduated), dermatologist2,3, Pitiporn Suwattee, assistant professor of dermatology4

1 University of Minnesota Medical School, Minneapolis, MN, 55455 USA , 2 Department of Dermatology, University of Minnesota, Minneapolis, MN, 55455 USA , 3 Private Practice, Fridley, MN, 55432 USA , 4 Minneapolis Veterans Affairs Medical Center, Minneapolis, MN, 55417 USA

Correspondence to: P Suwattee suwat001{at}umn.edu

A 53 year old, afebrile woman presented to the dermatology clinic with a two week history of petechial rash on her lower extremities that had progressed up to her arms. In addition, she also had pain in the wrists, knees, and elbows. Approximately five months earlier, she had been diagnosed with group A streptococcal pharyngeal infection, but she had not been treated with antibiotics. She was currently taking salbutamol, famciclovir, levothyroxine, lovastatin, and varenicline. A systems review was unremarkable and she had no reported haematuria, abdominal pain, or bloody stools.

A physical examination found multiple petechial macules, papules, and purpuric plaques, which were more numerous on the legs than on the arms (figure[F1]). A complete blood count and coagulation studies were normal. Urinalysis showed haematuria and proteinuria. A skin biopsy of a petechial papule revealed leucocytoclastic vasculitis, with a granular IgA reactivity around the blood vessels in the papillary dermis.


Figure FIG
View larger version (797K):
[in this window]
[in a new window]
[PowerPoint Slide for Teaching]
 
 

Questions

1 What additional investigative studies could be useful in a patient with palpable purpura?
2 What is the most likely diagnosis in our patient?
3 What are the adverse sequelae of this disease?

Answers

Short answers

1 Additional studies should include a faecal occult blood test, serology for hepatitis B and C, serum protein electrophoresis, anti-streptolysin O titre, and measurement of antinuclear antibodies, antineutrophil cytoplasmic antibodies, rheumatoid factor, serum immunoglobulins, and cryoglobulins. Abdominal ultrasound and renal biopsy may also be indicated.
2 The most likely diagnosis is Henoch-Schönlein purpura or anaphylactoid purpura, a leucocytoclastic vasculitis of small vessels.
3 Complications of Henoch-Schönlein purpura include nephritis or nephrotic syndrome, acute and chronic renal failure, gastrointestinal bleeding, intussusception, bowel obstruction, and bowel perforation.

Long answers
1 Investigations
Cutaneous palpable purpura may signify small vessel vasculitis, which has many possible causes (box 1).1 2 Histological findings of leucocytoclastic vasculitis include fibrin deposition in the vessel walls, red blood cell extravasation, and neutrophilic leucocytoclasis.


Box 1 Causes of leucocytoclastic vasculitis1 2
  • Infections: β haemolytic streptococcal infection, Clostridium difficile, Helicobacter pylori, Mycobacterium tuberculosis, bacterial endocarditis, hepatitis B, hepatitis C, HIV, measles, mumps, varicella, parvovirus B19, coxsackie virus, adenovirus
  • Drugs: non-steroidal anti-inflammatory drugs, β lactam antibiotics, diuretics, vancomycin, ranitidine, cefuroxime, diclofenac, streptokinase, and angiotensin converting enzyme inhibitors
  • Collagen vascular diseases: rheumatoid arthritis, systemic lupus erythematosus, Sjögren syndrome, mixed cryoglobulinaemia (type II and type III)
  • Inflammatory bowel disease: ulcerative colitis, Crohn’s disease
  • Primary systemic vasculitides: Henoch-Schönlein purpura, antineutrophil cytoplasmic antibody associated vasculitis, urticarial vasculitis, polyarteritis nodosa
  • Other: acute haemorraghic oedema of infancy, hairy cell leukaemia, multiple myeloma, non-Hodgkin’s lymphoma, prostate cancer, non-small cell lung cancer, food additives, exposure to cold


Patients who present with leucocytoclastic vasculitis should have a detailed history taken, and a thorough physical examination and laboratory work-up should be performed.2 A complete blood count, platelet count, peripheral blood smear, and coagulation studies help rule out haematological causes. Urinalysis, estimation of glomerular filtration rate, a liver function test, urine protein to creatinine ratio, analysis of urine sediment, and measurement of blood urea nitrogen, serum creatinine, and proteinuria should be undertaken to look for renal or hepatic involvement. Serum protein electrophoresis may also be helpful. A raised erythrocyte sedimentation rate and C reactive protein concentration indicate ongoing inflammation.

Serum complement, rheumatoid factor, antinuclear antibody, anti-double stranded DNA, extractable nuclear antigen, and antineutrophil cytoplasmic antibodies should be measured to search for immunological causes of leucocytoclastic vasculitis. Immunoglobulins should be measured because hypergammaglobulinaemia can cause purpura.

Serology for hepatitis B and C, serum cryoglobulins, and cryofibrinogens may also help pinpoint the cause of vasculitis. Chest radiography and blood and urine cultures can detect occult infection. A positive pharyngeal culture and raised anti-streptolysin O and anti-DNAse B titres may indicate streptococcal infection.

Echocardiography should be performed to look for endocarditis, and stools should be examined for occult blood to look for gastrointestinal involvement, especially if Henoch-Schönlein purpura is suspected.

2 Likely diagnosis
According to the new classification of vasculitides from the European League against Rheumatism (EULAR) and the Paediatric Rheumatology European Society (PRES), Henoch-Schönlein purpura is a type of non-granulomatous, predominantly small vessel vasculitis.3 Classic clinical features include palpable purpura, arthritis or arthralgias, and abdominal pain. Although diagnosis is typically made on a clinical basis only, skin biopsy is recommended in patients with atypical presentations. Henoch-Schönlein purpura is a small vessel vasculitis characterised by leucocytoclastic vasculitis with deposition of IgA and C3. Palpable purpura are mandatory for the diagnosis of Henoch-Schönlein purpura, according to the EULAR/PRES consensus (box 2).3


Box 2 Criteria for classification of Henoch-Schönlein purpura (2006)3
Palpable purpura (mandatory criterion) in the presence of at least one of the following features:

  • Diffuse abdominal pain
  • Any biopsy showing predominant IgA deposition
  • Arthritis (acute, any joint) or arthralgia
  • Renal involvement (haematuria or proteinuria)


In Henoch-Schönlein purpura, palpable purpura are typically located on the lower extremities, often extending to the extensor aspects of the arms and buttocks, and they are the presenting symptom in 75% of cases.4 The condition usually resolves without treatment but may recur and last up to four months, particularly in adults. Arthralgias and arthritis, although usually transient, may be the presenting symptom in only 15-25% of cases. They are caused by periarticular oedema and inflammation.4 5 6 Abdominal pain may occur as a result of petechial eruptions of the gastrointestinal tract that causes submucosal haemorrhage and oedema.7 Melaena, bright red blood in the stool, and haematemesis are possible manifestations of gastrointestinal involvement. A faecal occult blood test is an important diagnostic test which should be done in all patients with suspected Henoch-Schönlein purpura. Other rare systemic manifestations include subtle encephalopathy, seizures, cerebral haemorrhages, and diffuse alveolar haemorrhage.8 Swelling and tenderness of the scrotum and penis has been reported in boys, as a result of generalised oedema secondary to hypoalbuminaemia from renal and gastrointestinal involvement.8 Although the condition occurs mainly in children, it is also seen in adults. The tableGo highlights the differences between paediatric and adult presentations.


View this table:
[in this window]
[in a new window]

 
Differences between childhood and adult Henoch-Schönlein purpura9 10

 
Although the exact cause of Henoch-Schönlein purpura is unknown, it is thought to be an autoimmune reaction triggered by infection, particularly with group A streptococci, Clostridium difficile, Helicobacter pylori, Mycobacterium tuberculosis, measles, mumps, varicella, parvovirus B19, coxsackie virus, and adenovirus.11 12 Certain drugs are also implicated in the onset of the disease, including vancomycin, ranitidine, cefuroxime, diclofenac, streptokinase, and angiotensin converting enzyme inhibitors. Other reported associations are leukaemia, multiple myeloma, non-Hodgkin’s lymphoma, prostate cancer, non-small cell lung cancer, food allergies, and exposure to cold.12 13

The pathogenesis of Henoch-Schönlein purpura is not known, but deposits of an abnormal IgA1 isotype have been found in the skin, glomerular membrane, and gastrointestinal blood vessels. The abnormal glycosylation of the IgA1 isotype has been found to cause molecular instability, which increases the risk of proteolysis.14 Serum concentrations of tumour necrosis factor {alpha}, a proinflammatory cytokine, have been found to correlate with the degree of renal impairment in Henoch-Schönlein purpura.15 Polymorphism of the gene encoding interleukin 1β may also correlate with the severity of nephropathy. Polymorphisms of the angiotensinogen and angiotensin converting enzyme genes may play a role in the development and the severity of Henoch-Schönlein purpura and associated nephropathy, but the data are conflicting.14

3 Complications
Although Henoch-Schönlein purpura is generally a self limiting disease that lasts about a month, rare but serious gastrointestinal and renal complications may occur. As stated earlier, genetic polymorphisms may be the predisposing or protective factors in developing these complications.

One potentially serious gastrointestinal complication of Henoch-Schönlein purpura is intussusception, which occurs more commonly in children (1-5% of children with Henoch-Schönlein purpura).16 An abdominal ultrasound may be indicated in children with abdominal pain. Other less common complications include bowel perforation (with or without intussusception), pancreatitis, and massive gastrointestinal haemorrhage.17

Renal complications carry a high morbidity in patients with Henoch-Schönlein purpura. Although otherwise indistinguishable from IgA nephropathy, Henoch-Schönlein purpura associated nephritis may manifest with focal and segmental proliferative glomerulonephritis and crescent formation.14 IgA and C3 are deposited around the capillaries, venules, and in the glomeruli. In addition, IgG, IgM, and fibrin may be deposited in the renal mesangium. In one retrospective study with mean follow-up of just under five years, chronic renal insufficiency occurred in up to 15% of adults and 7% of children with kidney disease severe enough to warrant biopsy.18 In addition, proteinuria greater than 1 g in 24 hours may be associated with the development of end stage renal disease.19 Urine analysis will indicate the degree of haematuria and proteinuria, if any, and if these analyses are abnormal, kidney biopsy may be indicated.

Treatment of Henoch-Schönlein purpura is mainly supportive care and removal of possible precipitating causes. Analgesics are indicated for joint and abdominal pain.20 Systemic steroids have been used in patients with arthralgia or arthritis, gastrointestinal haemorrhages, and kidney involvement. These drugs do not stop or alter the courses of the disease process, particularly in the case of associated acute renal disease with haematuria and proteinuria.21 Cyclophosphamide, azathioprine, plasmapheresis, and intravenous immunoglobulin have shown limited success.8

Our patient had a kidney biopsy because of persistent haematuria and proteinuria. She was found to have IgA nephropathy with focal segmental necrosis and crescent formation.

She was treated with prednisolone 60 mg daily and her skin lesions rapidly improved. However, she developed hypertension and hyperglycaemia, probably as a result of the drug treatment. Prednisolone was lowered to 40 mg daily and subcutaneous insulin was started. Her hypertension and blood glucose subsequently improved. At follow-up her haematuria and proteinuria had resolved, and systemic steroids were gradually reduced.

Cite this as: BMJ 2009;338:b1284


Competing interests: None declared.

Provenance and peer review: Not commissioned; externally peer reviewed.

Patient consent obtained.

References

  1. Callen JP. Leukocytoclastic vasculitis. eMedicine, www.emedicine.com/med/topic2930.htm.
  2. Bolognia JL, Jorizzo JL, Rapini RP. Dermatology. 2nd ed. Philadelphia: Mosby,2007.
  3. Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 2006;65:936-41.[Abstract/Free Full Text]
  4. Habif TP. Clinical dermatology: a color guide to diagnosis and therapy. 4th ed. Philadelphia: Mosby, 2003.
  5. Trapani S, Micheli A, Grisolia F, Resti M, Chiappini E, Falcini F, et al. Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum 2005;35:143-53.[CrossRef][Web of Science][Medline]
  6. Kraft DM, Mckee D, Scott C. Henoch-Schönlein purpura: a review. Am Fam Physician 1998;58:405-8.[Web of Science][Medline]
  7. Gunasekaran TS. Henoch-Schönlein purpura: what does the "rash" look like in the gastrointestinal mucosa? Pediatr Dermatol 1997;14:437-40.[Web of Science][Medline]
  8. Tizard EJ, Hamilton-Ayres MJ. Henoch-Schönlein purpura. Arch Dis Child Educ Pract Ed 2008;93:1-8.[CrossRef][Medline]
  9. Ilan Y, Naparstek Y. Schönlein-Henoch syndrome in adults and children. Semin Arthritis Rheum 1991;21:103-9.[CrossRef][Web of Science][Medline]
  10. García-Porrúa C, Calviño MC, Llorca J, Couselo JM, González-Gay MA. Henoch-Schönlein purpura in children and adults: clinical differences in a defined population. Semin Arthritis Rheum 2002;32:149-56.[CrossRef][Web of Science][Medline]
  11. Kalman S, Ibrahim Aydin H, Atay A. Henoch-Schönlein purpura in a child following varicella. J Trop Pediatr 2005;51:240-1.[Abstract/Free Full Text]
  12. Rai A, Nast C, Adler S. Henoch-Schönlein purpura nephritis. J Am Soc Nephrol 1999;10:2637-44.[Free Full Text]
  13. Zurada JM, Ward KM, Grossman ME. Henoch-Schönlein purpura associated with malignancy in adults. J Am Acad Dermatol 2006;55(5 suppl):S65-70.[CrossRef][Web of Science][Medline]
  14. Tizard EJ, Hamilton-Ayres MJ. Henoch-Schönlein purpura. Arch Dis Child Educ Pract Ed 2008;93:1-8.[CrossRef][Medline]
  15. Ha TS. The role of tumor necrosis factor-alpha in Henoch-Schonlein purpura. Pediatr Nephrol 2005;20:149-53.[CrossRef][Web of Science][Medline]
  16. Saulsbury FT. Clinical update: Henoch-Schönlein purpura. Lancet 2007;369:976-8.[CrossRef][Web of Science][Medline]
  17. Cheung KM, Mok F, Lam P, Chan KH. Pancreatitis associated with Henoch-Schönlein purpura. J Paediatr Child Health 2001;37:311-3.[CrossRef][Web of Science][Medline]
  18. Coppo R, Mazzucco G, Cagnoli L, Lupo A, Schena FP. Longterm prognosis of Henoch-Schönlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schönlein purpura. Nephrol Dial Transplant 1997;12:2277-83.[Abstract/Free Full Text]
  19. Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D. Henoch-Schönlein purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 2002;13:1271-8.[Abstract/Free Full Text]
  20. Ebert EC. Gastrointestinal manifestations of Henoch-Schönlein purpura. Dig Dis Sci 2008;53:2011-9.[CrossRef][Web of Science][Medline]
  21. Weiss PF, Feinstein JA, Luan X, Burnham JM, Feudtner C. Effects of corticosteroid on Henoch-Schönlein purpura: a systematic review. Pediatrics 2007;120:1079-87.[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?



Access jobs at BMJ Careers
Whats new online at Student 

BMJ